nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—CYP2C9—brain cancer	0.691	1	CbGaD
Phenylbutazone—PTGS2—Etoposide—brain cancer	0.0604	0.262	CbGbCtD
Phenylbutazone—CYP3A4—Temozolomide—brain cancer	0.0581	0.252	CbGbCtD
Phenylbutazone—PTGS1—Etoposide—brain cancer	0.051	0.221	CbGbCtD
Phenylbutazone—CYP3A4—Lomustine—brain cancer	0.0494	0.214	CbGbCtD
Phenylbutazone—SLC22A8—choroid plexus—brain cancer	0.0128	0.269	CbGeAlD
Phenylbutazone—CYP3A4—Etoposide—brain cancer	0.0119	0.0517	CbGbCtD
Phenylbutazone—PTGIS—endothelium—brain cancer	0.00636	0.134	CbGeAlD
Phenylbutazone—PTGIS—blood vessel—brain cancer	0.00586	0.124	CbGeAlD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00428	0.165	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00297	0.115	CbGpPWpGaD
Phenylbutazone—PTGIS—endocrine gland—brain cancer	0.00179	0.0378	CbGeAlD
Phenylbutazone—PTGIS—head—brain cancer	0.00177	0.0374	CbGeAlD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00163	0.0632	CbGpPWpGaD
Phenylbutazone—PTGIS—central nervous system—brain cancer	0.00162	0.0341	CbGeAlD
Phenylbutazone—PTGIS—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00141	0.0546	CbGpPWpGaD
Phenylbutazone—PTGS1—ganglion—brain cancer	0.00138	0.0291	CbGeAlD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00132	0.0509	CbGpPWpGaD
Phenylbutazone—PTGIS—brain—brain cancer	0.00128	0.0271	CbGeAlD
Phenylbutazone—PTGS1—endothelium—brain cancer	0.00119	0.0251	CbGeAlD
Phenylbutazone—PTGIS—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00114	0.0442	CbGpPWpGaD
Phenylbutazone—PTGS2—endothelium—brain cancer	0.00114	0.024	CbGeAlD
Phenylbutazone—PTGS1—blood vessel—brain cancer	0.0011	0.0232	CbGeAlD
Phenylbutazone—PTGS2—blood vessel—brain cancer	0.00105	0.0221	CbGeAlD
Phenylbutazone—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00104	0.0404	CbGpPWpGaD
Phenylbutazone—SLC22A11—endocrine gland—brain cancer	0.001	0.0212	CbGeAlD
Phenylbutazone—Fosphenytoin—CYP2C9—brain cancer	0.00096	0.177	CrCbGaD
Phenylbutazone—Oxaprozin—CYP2C9—brain cancer	0.000923	0.17	CrCbGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000912	0.0353	CbGpPWpGaD
Phenylbutazone—Sulfinpyrazone—CYP2C9—brain cancer	0.000857	0.158	CrCbGaD
Phenylbutazone—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000724	0.028	CbGpPWpGaD
Phenylbutazone—SLC22A6—brain—brain cancer	0.000677	0.0143	CbGeAlD
Phenylbutazone—Phenprocoumon—CYP2C9—brain cancer	0.000658	0.121	CrCbGaD
Phenylbutazone—PTGIS—Biological oxidations—CYP2C9—brain cancer	0.000608	0.0235	CbGpPWpGaD
Phenylbutazone—SLC22A8—head—brain cancer	0.000559	0.0118	CbGeAlD
Phenylbutazone—PTGS1—telencephalon—brain cancer	0.000533	0.0112	CbGeAlD
Phenylbutazone—SLC22A8—central nervous system—brain cancer	0.000511	0.0108	CbGeAlD
Phenylbutazone—PTGS2—telencephalon—brain cancer	0.00051	0.0107	CbGeAlD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000502	0.0194	CbGpPWpGaD
Phenylbutazone—Modafinil—CYP2C9—brain cancer	0.000478	0.0881	CrCbGaD
Phenylbutazone—Dextropropoxyphene—CYP2C9—brain cancer	0.000473	0.0871	CrCbGaD
Phenylbutazone—PTGS1—pituitary gland—brain cancer	0.000434	0.00915	CbGeAlD
Phenylbutazone—Phenytoin—CYP2C9—brain cancer	0.000424	0.0781	CrCbGaD
Phenylbutazone—PTGS2—pituitary gland—brain cancer	0.000415	0.00875	CbGeAlD
Phenylbutazone—SLC22A8—brain—brain cancer	0.000405	0.00855	CbGeAlD
Phenylbutazone—PTGS2—medulla oblongata—brain cancer	0.0004	0.00844	CbGeAlD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000398	0.0154	CbGpPWpGaD
Phenylbutazone—PTGS1—spinal cord—brain cancer	0.000373	0.00787	CbGeAlD
Phenylbutazone—CYP2C9—endocrine gland—brain cancer	0.000368	0.00777	CbGeAlD
Phenylbutazone—PTGS2—midbrain—brain cancer	0.000366	0.00772	CbGeAlD
Phenylbutazone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000362	0.014	CbGpPWpGaD
Phenylbutazone—PTGS2—spinal cord—brain cancer	0.000357	0.00753	CbGeAlD
Phenylbutazone—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000352	0.0136	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000348	0.0135	CbGpPWpGaD
Phenylbutazone—PTGS1—endocrine gland—brain cancer	0.000336	0.00709	CbGeAlD
Phenylbutazone—Diphenhydramine—CYP2C9—brain cancer	0.000332	0.0612	CrCbGaD
Phenylbutazone—PTGS1—head—brain cancer	0.000332	0.007	CbGeAlD
Phenylbutazone—PTGS2—endocrine gland—brain cancer	0.000321	0.00678	CbGeAlD
Phenylbutazone—Methadone—CYP2C9—brain cancer	0.000321	0.0591	CrCbGaD
Phenylbutazone—PTGS2—head—brain cancer	0.000317	0.00669	CbGeAlD
Phenylbutazone—PTGS1—central nervous system—brain cancer	0.000303	0.00639	CbGeAlD
Phenylbutazone—PTGS2—central nervous system—brain cancer	0.00029	0.00611	CbGeAlD
Phenylbutazone—PTGS2—cerebellum—brain cancer	0.000283	0.00597	CbGeAlD
Phenylbutazone—CYP3A4—endocrine gland—brain cancer	0.000281	0.00592	CbGeAlD
Phenylbutazone—CYP3A4—central nervous system—brain cancer	0.000253	0.00534	CbGeAlD
Phenylbutazone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000249	0.00962	CbGpPWpGaD
Phenylbutazone—PTGS1—brain—brain cancer	0.000241	0.00507	CbGeAlD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000237	0.00916	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000233	0.00903	CbGpPWpGaD
Phenylbutazone—PTGS2—brain—brain cancer	0.00023	0.00485	CbGeAlD
Phenylbutazone—PTGIS—Adipogenesis—IRS2—brain cancer	0.000228	0.00883	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000187	0.00722	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—DTX2—brain cancer	0.000184	0.00711	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000171	0.0066	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—S100A10—brain cancer	0.00016	0.00618	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000157	0.00608	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00015	0.00582	CbGpPWpGaD
Phenylbutazone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000148	0.00574	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000147	0.00567	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000137	0.0053	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—CTNNB1—brain cancer	0.000137	0.0053	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HES5—brain cancer	0.000135	0.00522	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000128	0.00497	CbGpPWpGaD
Phenylbutazone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000128	0.00494	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000122	0.00472	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000122	0.00471	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—STAT3—brain cancer	0.000119	0.00462	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000115	0.00445	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000114	0.00443	CbGpPWpGaD
Phenylbutazone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000113	0.00438	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000112	0.00434	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP2C9—brain cancer	0.000104	0.00402	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000102	0.00393	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—HES1—brain cancer	9.45e-05	0.00365	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	9.09e-05	0.00351	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IDH1—brain cancer	9.07e-05	0.00351	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—BSG—brain cancer	8.84e-05	0.00342	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	8.82e-05	0.00341	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HEY1—brain cancer	8.6e-05	0.00333	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—DLL1—brain cancer	8.44e-05	0.00326	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	7.88e-05	0.00305	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—IDH1—brain cancer	7.6e-05	0.00294	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	7.47e-05	0.00289	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	7.43e-05	0.00288	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	7.38e-05	0.00285	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.17e-05	0.00277	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ENO2—brain cancer	7.17e-05	0.00277	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SHH—brain cancer	7.17e-05	0.00277	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	6.75e-05	0.00261	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	6.62e-05	0.00256	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.48e-05	0.0025	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.39e-05	0.00247	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	6.35e-05	0.00246	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	6.31e-05	0.00244	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.21e-05	0.0024	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.19e-05	0.00239	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.08e-05	0.00235	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ENO2—brain cancer	6.01e-05	0.00232	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.69e-05	0.0022	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	5.66e-05	0.00219	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CDK4—brain cancer	5.65e-05	0.00218	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	5.63e-05	0.00218	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	5.25e-05	0.00203	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.25e-05	0.00203	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—VAV1—brain cancer	5.18e-05	0.002	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.18e-05	0.002	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.08e-05	0.00196	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.02e-05	0.00194	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	4.79e-05	0.00185	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	4.7e-05	0.00182	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.66e-05	0.0018	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—DTX2—brain cancer	4.48e-05	0.00173	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HES1—brain cancer	4.46e-05	0.00172	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.44e-05	0.00172	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PDGFRA—brain cancer	4.24e-05	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.16e-05	0.00161	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.84e-05	0.00149	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MYC—brain cancer	3.84e-05	0.00148	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—brain cancer	3.74e-05	0.00145	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IRS2—brain cancer	3.73e-05	0.00144	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCND1—brain cancer	3.65e-05	0.00141	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.62e-05	0.0014	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APC—brain cancer	3.29e-05	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HES5—brain cancer	3.29e-05	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP2C9—brain cancer	3.19e-05	0.00124	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MYC—brain cancer	2.92e-05	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—EGFR—brain cancer	2.86e-05	0.00111	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.81e-05	0.00109	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.76e-05	0.00107	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CG—brain cancer	2.76e-05	0.00107	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BSG—brain cancer	2.72e-05	0.00105	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB2—brain cancer	2.55e-05	0.000988	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2C9—brain cancer	2.54e-05	0.000981	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.48e-05	0.000959	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.46e-05	0.00095	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—brain cancer	2.4e-05	0.000929	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—IDH1—brain cancer	2.34e-05	0.000903	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—brain cancer	2.24e-05	0.000864	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IDH1—brain cancer	2.21e-05	0.000856	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.16e-05	0.000836	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BSG—brain cancer	2.16e-05	0.000834	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HEY1—brain cancer	2.1e-05	0.000812	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—DLL1—brain cancer	2.06e-05	0.000796	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.99e-05	0.000769	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—brain cancer	1.95e-05	0.000754	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.95e-05	0.000753	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.9e-05	0.000736	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—IDH1—brain cancer	1.85e-05	0.000717	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ENO2—brain cancer	1.85e-05	0.000714	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—brain cancer	1.81e-05	0.0007	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—brain cancer	1.77e-05	0.000685	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SHH—brain cancer	1.75e-05	0.000677	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ENO2—brain cancer	1.75e-05	0.000677	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.63e-05	0.000632	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.51e-05	0.000584	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ENO2—brain cancer	1.47e-05	0.000567	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BSG—brain cancer	1.43e-05	0.000552	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—VAV1—brain cancer	1.26e-05	0.000489	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—IDH1—brain cancer	1.23e-05	0.000475	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.11e-05	0.000428	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HES1—brain cancer	1.09e-05	0.000421	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFRA—brain cancer	1.04e-05	0.0004	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1e-05	0.000387	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ENO2—brain cancer	9.71e-06	0.000375	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BSG—brain cancer	9.42e-06	0.000364	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS2—brain cancer	9.09e-06	0.000352	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—brain cancer	8.47e-06	0.000328	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—IDH1—brain cancer	8.1e-06	0.000313	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—brain cancer	8.03e-06	0.000311	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—brain cancer	6.72e-06	0.00026	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ENO2—brain cancer	6.4e-06	0.000248	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—brain cancer	6.23e-06	0.000241	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—brain cancer	5.45e-06	0.000211	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—brain cancer	4.75e-06	0.000184	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—brain cancer	4.45e-06	0.000172	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—brain cancer	4.42e-06	0.000171	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—brain cancer	4.32e-06	0.000167	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—brain cancer	2.94e-06	0.000114	CbGpPWpGaD
